MedTrace Logo

Assessment of NSAID-treated Patients Adherence to Co-prescribed Proton Pump Inhibitor (PPI)

NCT01519375 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 102

Last updated 2012-05-30

No results posted yet for this study

Summary

The primary objective of this cross-sectional observational real life study is to investigate the patient reported adherence to PPI, when prescribed as prevention of NSAID associated GI Ulcers to patients prescribed a NSAID. Patients included have Osteoarthritis, Rheumatoid Arthritis or Ankylosing Spondylitis. Adherence will be assessed by patient questionnaires.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Georgios Stratelis, MD, PhD · AstraZeneca Nordics, B674:4 151 87 Södertälje, Sweden

  • Kenneth Henriksson, MD · Reuma City, 111 52 Stockholm, Sweden

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2012-05-31
Completion
2012-05-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01519375 on ClinicalTrials.gov